These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39420554)

  • 1. Imaging Glucose Metabolism and Dopaminergic Dysfunction in Sheep (
    Williams GK; Akkermans J; Lawson M; Syta P; Staelens S; Adhikari MH; Morton AJ; Nitzsche B; Boltze J; Christou C; Bertoglio D; Ahamed M
    ACS Chem Neurosci; 2024 Nov; 15(21):4082-4091. PubMed ID: 39420554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
    Feigin A; Leenders KL; Moeller JR; Missimer J; Kuenig G; Spetsieris P; Antonini A; Eidelberg D
    J Nucl Med; 2001 Nov; 42(11):1591-5. PubMed ID: 11696626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
    López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT: an unexpected case of Huntington's disease.
    Michels S; Buchholz HG; Rosar F; Heinrich I; Hoffmann MA; Schweiger S; Tüscher O; Schreckenberger M
    BMC Neurol; 2019 May; 19(1):78. PubMed ID: 31043171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease.
    Delva A; Van Laere K; Vandenberghe W
    Mov Disord; 2023 Aug; 38(8):1515-1526. PubMed ID: 37382295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Alterations in Aged OVT73 Sheep Model of Huntington's Disease: An MRI Based Approach.
    Taghian T; Gallagher J; Batcho E; Pullan C; Kuchel T; Denney T; Perumal R; Moore S; Muirhead R; Herde P; Johns D; Christou C; Taylor A; Passler T; Pulaparthi S; Hall E; Chandra S; O'Neill CA; Gray-Edwards H
    J Huntingtons Dis; 2022; 11(4):391-406. PubMed ID: 36189602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced D
    Weiss AR; Bertoglio D; Liguore WA; Brandon K; Templon J; Link J; McBride JL
    Mov Disord; 2023 Jan; 38(1):143-147. PubMed ID: 36544385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.
    Handley RR; Reid SJ; Brauning R; Maclean P; Mears ER; Fourie I; Patassini S; Cooper GJS; Rudiger SR; McLaughlan CJ; Verma PJ; Gusella JF; MacDonald ME; Waldvogel HJ; Bawden CS; Faull RLM; Snell RG
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11293-E11302. PubMed ID: 29229845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up Study.
    Reilmann R; Lippross V; Hölzner E; Gigengack F; Bohlen S; Kugel H; Deppe M; Osada N; Lücke M; Riess O; Nguyen HP; Von Hörsten S; Schäfers K; Schäfers M; Jacobs AH; Hermann S
    J Huntingtons Dis; 2015; 4(1):37-47. PubMed ID: 26333256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic Analysis of Plasma in Huntington's Disease Transgenic Sheep (Ovis aries) Reveals Progressive Circadian Rhythm Dysregulation.
    Spick M; Hancox TPM; Chowdhury NR; Middleton B; Skene DJ; Morton AJ
    J Huntingtons Dis; 2023; 12(1):31-42. PubMed ID: 36617787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease.
    Agosta F; Altomare D; Festari C; Orini S; Gandolfo F; Boccardi M; Arbizu J; Bouwman F; Drzezga A; Nestor P; Nobili F; Walker Z; Pagani M;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1546-1556. PubMed ID: 29717332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of PET imaging in Huntington's disease.
    Pagano G; Niccolini F; Politis M
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1171-82. PubMed ID: 26899245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
    Ciarmiello A; Cannella M; Lastoria S; Simonelli M; Frati L; Rubinsztein DC; Squitieri F
    J Nucl Med; 2006 Feb; 47(2):215-22. PubMed ID: 16455626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D
    Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Dominguez C; Munoz-Sanjuan I; Skinbjerg M; Liu L; Staelens S
    Mol Imaging Biol; 2021 Apr; 23(2):208-219. PubMed ID: 33179158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal patterns of sleep and EEG power distribution during non-rapid eye movement sleep in the sheep model of Huntington's disease.
    Vas S; Nicol AU; Kalmar L; Miles J; Morton AJ
    Neurobiol Dis; 2021 Jul; 155():105367. PubMed ID: 33848636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Imaging in Huntington's Disease.
    Roussakis AA; Piccini P
    J Huntingtons Dis; 2015; 4(4):287-96. PubMed ID: 26683130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Brain Glucose Metabolism Following Cardiac Arrest by [
    Zhang HJ; Mitchell S; Fang YH; Tsai HM; Piao L; Ousta A; Leoni L; Chen CT; Sharp WW
    Neurocrit Care; 2021 Feb; 34(1):64-72. PubMed ID: 32358767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study.
    Delva A; Michiels L; Koole M; Van Laere K; Vandenberghe W
    Neurology; 2022 Jan; 98(1):e83-e94. PubMed ID: 34663644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further molecular characterisation of the OVT73 transgenic sheep model of Huntington's disease identifies cortical aggregates.
    ; Reid SJ; Patassini S; Handley RR; Rudiger SR; McLaughlan CJ; Osmand A; Jacobsen JC; Morton AJ; Weiss A; Waldvogel HJ; MacDonald ME; Gusella JF; Bawden CS; Faull RL; Snell RG
    J Huntingtons Dis; 2013; 2(3):279-95. PubMed ID: 25062676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.